ホーム > 研究活動:研究報告

研究報告:2016年

前のページに戻る

1.      Orimo S, Yogo M, Nakamura T, Suzuki M, Watanabe H: (123)I-meta-iodobenzylguanidine (MIBG) cardiac scintigraphy in α-synucleinopathies. Ageing Res Rev. Feb, 2016

2.      Maeda O, Yokota K, Atsuta N, Katsuno M, Akiyama M, Ando Y: Nivolumab for the treatment of malignant melanoma in a patient with pre-existing myasthenia gravis. Nagoya J Med Sci. 78: 119–122, 2016

3.      Nakamura R, Sone J, Atsuta N, Tohnai G, Watanabe H, Yokoi D, Nakatochi M, Watanabe H, Ito M, Senda J, Katsuno M, Tanaka F, Li Y, Izumi Y, Morita M, Taniguchi A, Kano O, Oda M, Kuwabara S, Abe K, Aiba I, Okamoto K, Mizoguchi K, Hasegawa K, Aoki M, Hattori N, Tsuji S, Nakashima K, Kaji R, Sobue G ; Japanese Consortium for Amyotrophic Lateral Sclerosis Research (JaCALS): Next-generation sequencing of 28 ALS-related genes in a Japanese ALS cohort. Neurobiol Aging. 39: 219.e1–8, 2016

4.      Senda J, Ito K, Kotake T, Kanamori M, Kishimoto H, Kadono I, Suzuki Y, Katsuno M, Nishida Y, Ishiguro N, Sobue G: Association of Leukoaraiosis With Convalescent Rehabilitation Outcome in Patients With Ischemic Stroke. Stroke. 47: 160–166, 2016

5.      Araki K, Ito M, Atsuta N, Katsuno M, Sobue G: Serial magnetic resonance angiography in a patient with angioinvasive aspergillosis. Neurology and Clinical Neuroscience. 4: 73–75, 2016

6.      Yoritaka A, Abe T, Ohtsuka C, Maeda T, Hirayama M, Watanabe H, Saiki H, Oyama G, Fukae J, Shimo Y, Hatano T, Kawajiri S, Okuma Y, Machida Y, Miwa H, Suzuki C, Kazama A, Tomiyama M, Kihara T, Hirasawa M, Shimura H, Hattori N: A randomized double-blind multi-center trial of hydrogen water for Parkinson’s disease: protocol and baseline characteristics. BMC Neurol. 16: 66, 2016

7.      Kimura T, Tucker A, Sugimura T, Seki T, Fukuda S, Takeuchi S, Miyata S, Fujita T, Hashizume A, Izumi N, Kawasaki K, Katsuno M, Hashimoto M, Sako K: Ultra-Early Combination Antiplatelet Therapy with Cilostazol for the Prevention of Branch Atheromatous Disease: A Multicenter Prospective Study. Cerebrovasc Dis Extra. 6: 84–95, 2016

8.      Noda T, Iijima M, Noda S, Maeshima S, Nakanishi H, Kimura S, Koike H, Ishigaki S, Iguchi Y, Katsuno M, Sobue G: Gene Expression Profile of Inflammatory Myopathy with Malignancy is Similar to that of Dermatomyositis rather than Polymyositis. Intern Med. 55: 2571–2580, 2016

9.      Ando T, Goto Y, Mano K, Ueda A, Ando Y, Mizuta I, Mizuno T: CADASIL Presenting as Acute Bilateral Multiple Subcortical Infarcts without a Characteristic Temporal Pole or Any External Capsule Lesions. Intern Med. 55: 2873–2876, 2016

10.    Okada A, Nakamura T, Suzuki J, Suzuki M, Hirayama M, Katsuno M, Sobue G: Impaired Pain Processing Correlates with Cognitive Impairment in Parkinson’s Disease. Intern Med. 55: 3113–3118, 2016

11.    Hirayama M, Minato T, Maeda T, Nakamura T, Katsuno M: Efficacy of a novel drug zonisamide in the modulation of oxidative stress in Parkinson’s disease. Neurology and Clinical Neuroscience. 5: 49–54, 2016

12.    Hirayama M, Tsunoda M, Yamamoto M, Tsuda T, Ohno K: Serum tyrosine-to-phenylalanine ratio is low in Parkinson’s disease. Journal of Parkinson’s disease. 2-6: 423–431, 2016

13.    Pourshafie N, Lee PR, Chen KL, Harmison GG, Bott LC, Katsuno M, Sobue G, Burnett BG, Fischbeck KH, Rinaldi C: MiR-298 Counteracts Mutant Androgen Receptor Toxicity in Spinal and Bulbar Muscular Atrophy. Mol Ther. 24: 937–945, 2016

14.    Xu Y, Halievski K, Henley C, Atchison WD, Katsuno M, Adachi H, Sobue G, Breedlove SM, Jordan CL: Defects in Neuromuscular Transmission May Underlie Motor Dysfunction in Spinal and Bulbar Muscular Atrophy. J Neurosci. 36: 5094–5106, 2016

15.    Bott LC, Badders NM, Chen KL, Harmison GG, Bautista E, Shih CC, Katsuno M, Sobue G, Taylor JP, Dantuma NP, Fischbeck KH, Rinaldi C: A small-molecule Nrf1 and Nrf2 activator mitigates polyglutamine toxicity in spinal and bulbar muscular atrophy. Hum Mol Genet. 25: 1979–1989, 2016

16.    Hirunagi T, Tsujikawa K, Hasegawa Y, Mano K, Katsuno M: Elderly-onset familial myasthenia gravis in two siblings. Neuromuscul Disord. 26: 347–349, 2016

17.    Yokoi D, Atsuta N, Watanabe H, Nakamura R, Hirakawa A, Ito M, Watanabe H, Katsuno M, Izumi Y, Morita M, Taniguchi A, Oda M, Abe K, Mizoguchi K, Kano O, Kuwabara S, Kaji R, Sobue G; JaCALS: Age of onset differentially influences the progression of regional dysfunction in sporadic amyotrophic lateral sclerosis. J Neurol. 263: 1129–1136, 2016

18.    Ikumi K, Ando T, Katano H, Katsuno M, Sakai Y, Yoshida M, Saida T, Kimura H, Sobue G: HSV-2-related hemophagocytic lymphohistiocytosis in a fingolimod-treated patient with MS. Neurol Neuroimmunol Neuroinflamm. 3: e247, 2016

19.    Ando T, Goto Y, Mano K: Upper back restlessness: Two case reports. J Neurol Sci. 365: 137–138, 2016

20.    Kubo S, Hamada S, Maeda T, Uchiyama T, Hashimoto M, Nomoto N, Kano O, Takahashi T, Terashi H, Takahashi T, Hatano T, Hasegawa T, Baba Y, Sengoku R, Watanabe H, Kadowaki T, Inoue M, Kaneko S, Shimura H, Nagayama H: A Japanese multicenter survey characterizing pain in Parkinson’s disease. J Neurol Sci. 365: 162–166, 2016

21.    Ohyama K, Koike H, Hashimoto R, Takahashi M, Kawagashira Y, Iijima M, Katsuno M, Sobue G: Intraepidermal nerve fibre density in POEMS (Crow-Fukase) syndrome and the correlation with sural nerve pathology. J Neurol Sci. 365: 207–211, 2016

22.    Nakashima H, Ohkawara B, Ishigaki S, Fukudome T, Ito K, Tsushima M, Konishi H, Okuno T, Yoshimura T, Ito M, Masuda A, Sobue G, Kiyama H, Ishiguro N, Ohno K: R-spondin 2 promotes acetylcholine receptor clustering at the neuromuscular junction via Lgr5. Sci Rep. 6: 28512, 2016

23.    Hijikata Y, Katsuno M, Suzuki K, Hashizume A, Araki A, Yamada S, Inagaki T, Iida M, Noda S, Nakanishi H, Banno H, Mano T, Hirakawa A, Adachi H, Watanabe H, Yamamoto M, Sobue G: Impaired muscle uptake of creatine in spinal and bulbar muscular atrophy. Ann Clin Transl Neurol. 3: 537–546, 2016

24.    Riku Y, Watanabe H, Yoshida M, Mimuro M, Iwasaki Y, Masuda M, Ishigaki S, Katsuno M, Sobue G: Marked Involvement of the Striatal Efferent System in TAR DNA-Binding Protein 43kDa-Related Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis. J Neuropathol Exp Neurol. 75: 801–811, 2016

25.    Ding Y, Adachi H, Katsuno M, Sahashi K, Kondo N, Iida M, Tohnai G, Nakatsuji H, Sobue G: BIIB021, a synthetic Hsp90 inhibitor, induces mutant ataxin-1 degradation through the activation of heat shock factor 1. Neuroscience. 327: 20–31, 2016
Iwatsuki K, Yoshida A, Shinohara T, Nakano T, Uemura J, Goto S, Hirayama M, Hoshiyama M, Hirata H: Recovery function of somatosensory evoked brain response in patients with carpal tunnel syndrome: A magnetoencephalographic study. Clin Neurophysiol. 127: 2733–2738, 2016

26.    Watanabe H, Atsuta N, Hirakawa A, Nakamura R, Nakatochi M, Ishigaki S, Iida A, Ikegawa S, Kubo M, Yokoi D, Watanabe H, Ito M, Katsuno M, Izumi Y, Morita M, Kanai K, Taniguchi A, Aiba I, Abe K, Mizoguchi K, Oda M, Kano O, Okamoto K, Kuwabara S, Hasegawa K, Imai T, Kawata A, Aoki M, Tsuji S, Nakashima K, Kaji R, Sobue G: A rapid functional decline type of amyotrophic lateral sclerosis is linked to low expression of TTN. J Neurol Neurosurg Psychiatry. 87: 851–858, 2016

27.    Yoshida T, Ueki Y, Suzuki T, Kawagashira Y, Koike H, Kusumoto S, Ida S, Oguri T, Omura M, Sobue, Matsukawa N: Guillain-Barré syndrome after allogeneic bone marrow transplantation: Case report and literature review. eNeurologicalSci. 4: 52–55, 2016

28.    Watanabe Y, Beeldman E, Raaphorst J, Izumi Y, Yoshino H, Masuda M, Atsuta N, Ito S, Adachi T, Adachi Y, Yokota O, Oda M, Hanashima R, Ogino M, Ichikawa H, Hasegawa K, Kimura H, Shimizu T, Aiba I, Yabe H, Kanba M, Kusumi K, Aoki T, Hiroe Y, Watanabe H, Nishiyama K, Nomoto M, Sobue G, Nakashima K; ALS-FTD-Q-J Research Group: Japanese version of the ALS-FTD-Questionnaire (ALS-FTD-Q-J). J Neurol Sci. 367: 51–55, 2016

29.    Tsujikawa K, Hara K, Muro Y, Nakanishi H, Niwa Y, Koike M, Noda S, Riku Y, Sahashi K, Atsuta N, Ito M, Shimoyama Y, Akiyama M, Katsuno M: HMGCR antibody-associated myopathy as a paraneoplastic manifestation of esophageal carcinoma. Neurology. 87: 841–843, 2016

30.    Fujita K, Motoki K, Tagawa K, Chen X, Hama H, Nakajima K, Homma H, Tamura T, Watanabe H, Katsuno M, Matsumi C, Kajikawa M, Saito T, Saido T, Sobue G, Miyawaki A, Okazawa H: HMGB1, a pathogenic molecule that induces neurite degeneration via TLR4-MARCKS, is a potential therapeutic target for Alzheimer’s disease. Sci Rep. 6: 31895, 2016

31.    Nakamura T, Suzuki M, Okada A, Suzuki J, Hasegawa S, Koike H, Hirayama M, Katsuno M, Sobue G: Association of leptin with orthostatic blood pressure changes in Parkinson’s disease. Mov Disord. 31: 1417–1421, 2016

32.    Orimo S, Yogo M, Nakamura T, Suzuki M, Watanabe H: (123)I-meta-iodobenzylguanidine (MIBG) cardiac scintigraphy in α-synucleinopathies. Ageing Res Rev. 30: 122–133, 2016

33.    Tsujikawa K, Senda J, Yasui K, Hasegawa Y, Hoshiyama M, Katsuno M, Sobue G: Distinctive distribution of brain volume reductions in MELAS and mitochondrial DNA A3243G mutation carriers: A voxel-based morphometric study. Mitochondrion. 30: 229–235, 2016

34.    Misawa S, Sato Y, Katayama K, Nagashima K, Aoyagi R, Sekiguchi Y, Sobue G, Koike H, Yabe I, Sasaki H, Watanabe O, Takashima H, Nishizawa M, Kawachi I, Kusunoki S, Mitsui Y, Kikuchi S, Nakashima I, Ikeda S, Kohara N, Kanda T, Kira J, Hanaoka H, Kuwabara S; Japanese POEMS Syndrome for Thalidomide (J-POST) Trial Study Group: Safety and efficacy of thalidomide in patients with POEMS syndrome: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 15: 1129–1137, 2016

35.    Kino Y, Washizu C, Kurosawa M, Yamada M, Doi H, Takumi T, Adachi H, Katsuno M, Sobue G, Hicks GG, Hattori N, Shimogori T, Nukina N: FUS/TLS acts as an aggregation-dependent modifier of polyglutamine disease model mice. Sci Rep. 6: 35236, 2016

36.    Tanaka Y, Tsuboi T, Watanabe H, Kajita Y, Nakatsubo D, Fujimoto Y, Ohdake R, Ito M, Atsuta N, Yamamoto M, Wakabayashi T, Katsuno M, Sobue G: Articulation Features of Parkinson’s Disease Patients with Subthalamic Nucleus Deep Brain Stimulation. J Parkinsons Dis. 6: 811–819, 2016

37.    Masuda M, Senda J, Watanabe H, Epifanio B, Tanaka Y, Imai K, Riku Y, Li Y, Nakamura R, Ito M, Ishigaki S, Atsuta N, Koike H, Katsuno M, Hattori N, Naganawa S, Sobue G: Involvement of the caudate nucleus head and its networks in sporadic amyotrophic lateral sclerosis-frontotemporal dementia continuum. Amyotroph Lateral Scler Frontotemporal Degener. 17: 571–579, 2016

38.    Erratum in: Amyotroph Lateral Scler Frontotemporal Degener. 17, 2016 Ando T, Araki A, Terao S, Saka Y: Bilateral internal capsule lesions in uremic encephalopathy. Neurology and Clinical Neuroscience. 4: 243, 2016

39.    Yamaguchi N, Misawa S, Sato Y, Nagashima K, Katayama K, Sekiguchi Y, Iwai Y, Amino H, Suichi T, Yokota T, Nishida Y, Kohara N, Hirata K, Nishiyama K, Yabe I, Kaida KI, Suzuki N, Nodera H, Tsuji S, Koike H, Kira JI, Hanaoka H, Kusunoki S, Kuwabara S; JET-GBS Group: A Prospective, Multicenter, Randomized Phase II Study to Evaluate the Efficacy and Safety of Eculizumab in Patients with Guillain-Barré Syndrome (GBS): Protocol of Japanese Eculizumab Trial for GBS (JET-GBS). JMIR Res Protoc. 5: e210, 2016

40.    Koike H, Ikeda S, Takahashi M, Kawagashira Y, Iijima M, Misumi Y, Ando Y, Ikeda SI, Katsuno M, Sobue G: Schwann cell and endothelial cell damage in transthyretin familial amyloid polyneuropathy. Neurology. 87: 2220–2229, 2016

41.    Yokoi S, Yasui K, Hasegawa Y, Niwa K, Noguchi Y, Tsuzuki T, Mimuro M, Sone J, Watanabe H, Katsuno M, Yoshida M, Sobue G: Pathological background of subcortical hyperintensities on diffusion-weighted images in a case of neuronal intranuclear inclusion disease. Clin Neuropathol. 35: 375–380, 2016

42.    Senda J, Watanabe H, Endo K, Yasui K, Hawsegawa Y, Yoneyama N, Tsuboi T, Hara K, Ito M, Atsuta N, Epifanio B Jr, Katsuno M, Naganawa S, Sobue G: Active brain changes after initiating fingolimod therapy in multiple sclerosis patients using individual voxel-based analyses for diffusion tensor imaging. Nagoya J Med Sci. 78: 455–463, 2016

43.    Sone J, Mori K, Inagaki T, Katsumata R, Takagi S, Yokoi S, Araki K, Kato T, Nakamura T, Koike H, Takashima H, Hashiguchi A, Kohno Y, Kurashige T, Kuriyama M, Takiyama Y, Tsuchiya M, Kitagawa N, Kawamoto M, Yoshimura H, Suto Y, Nakayasu H, Uehara N, Sugiyama H, Takahashi M, Kokubun N, Konno T, Katsuno M, Tanaka F, Iwasaki Y, Yoshida M, Sobue G: Clinicopathological features of adult-onset neuronal intranuclear inclusion disease. Brain. 139: 3170–3186, 2016

44.    Iguchi Y, Eid L, Parent M, Soucy G, Bareil C, Riku Y, Kawai K, Takagi S, Yoshida M, Katsuno M, Sobue G, Julien JP: Exosome secretion is a key pathway for clearance of pathological TDP-43. Brain. 139: 3187–3201, 2016

45.    Kadoya M, Kaida K, Koike H, Takazaki H, Ogata H, Moriguchi K, Shimizu J, Nagata E, Takizawa S, Chiba A, Yamasaki R, Kira JI, Sobue G, Ikewaki K: IgG4 anti-neurofascin155 antibodies in chronic inflammatory demyelinating polyradiculoneuropathy: Clinical significance and diagnostic utility of a conventional assay. J Neuroimmunol. 301: 16–22, 2016

46.    Yamada S, Hashizume A, Hijikata Y, Inagaki T, Suzuki K, Kondo N, Kawai K, Noda S, Nakanishi H, Banno H, Hirakawa A, Koike H, Halievski K, Jordan CL, Katsuno M, Sobue G: Decreased Peak Expiratory Flow Associated with Muscle Fiber-Type Switching in Spinal and Bulbar Muscular Atrophy. PLoS One. 11: e0168846, 2016

ページトップに戻る
COPYRIGHT © NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE. ALL RIGHTS RESERVED.